Journal Policy

At the Journal of Pharmaceutical Research and Integrated Medical Sciences (JPRIMS), we take pride in our rigorous, transparent, double-blind peer review process. This procedure ensures our published research's quality, credibility, and impartiality. Here's an overview of our peer review process:

1. Submission: Authors submit their manuscripts through our user-friendly online submission system.
2. Initial Assessment: Upon submission, our editorial team conducts an initial assessment to ensure that the manuscript adheres to our submission guidelines and is suitable for peer review.
3. Double-Blind Review:
• Assignment: The manuscript is assigned to two expert reviewers with relevant expertise in the field. These reviewers are carefully selected to maintain anonymity.
• Blind Review: Reviewers evaluate the manuscript without knowledge of the authors' identities, and vice versa. This double-blind process ensures an unbiased assessment.
4. Peer Review Evaluation: Reviewers thoroughly evaluate the manuscript, considering factors such as originality, methodology, significance, and presentation.
5. Reviewer Recommendations
• Acceptance: If both reviewers recommend acceptance, the manuscript moves to the acceptance stage.
• Revision: If reviewers suggest revisions, authors are invited to make the necessary improvements.
• Rejection: If reviewers recommend rejection, the manuscript undergoes further assessment by our editorial team.
6. Editorial Decision: Based on reviewer recommendations and editorial evaluation, the Editor-in-Chief makes a final decision:
• Acceptance: The manuscript is accepted for publication.
• Minor Revisions: Authors are required to address minor revisions suggested by reviewers.
• Major Revisions: Authors must make significant revisions and resubmit the manuscript.
• Rejection: Manuscripts that do not meet our quality standards may be rejected.
7. Author Revision: Authors have the opportunity to revise their manuscripts based on reviewer feedback and editorial recommendations.
8. Final Review: Revised manuscripts undergo a final review to ensure that all revisions have been appropriately addressed.
9. Publication: Accepted manuscripts are published in the next available issue.
10. Post-Publication Engagement: Engage with your readers and the global research community through our interactive platform. Discuss your research findings, answer questions, and contribute to ongoing scientific dialogue. Our commitment to double-blind peer review ensures that your research is rigorously evaluated and that our readers can trust the quality of the content we publish. We value transparency, integrity, and collaboration, and our peer review process is a testament to these principles.

Publication Ethics and Plagiarism Policy

Journal of Pharmaceutical Research and Integrated Medical Sciences (JPRIMS) will strictly adhere to the plagiarism policy. The content of the manuscript should not be plagiarized and proper references must be provided for the information that was extracted from various sources of the literature available. All the submitted manuscripts will be screened by using the Plagiarism Detection Software. Authors should obtain necessary permissions for using copyright material in terms of artwork, adaptations, etc.

Plagiarism in any form is not acceptable under any circumstances. A declaration of original work must be submitted with the final article, failing which the article will not be considered for editorial screening. Author/s must ensure the authenticity of the articles. Any unethical behavior (plagiarism, false data, etc.) may lead to the rejection of the article at any stage (peer review, editing, etc.). Published articles may be withdrawn if plagiarism and/or falsifying results are indicated.

To handle the cases of research and publication misconduct, (JPRIMS) follows the guidelines issued by the Committee on Publication Ethics (COPE).